Literature DB >> 3533686

Lymphocyte subsets and activation in prediabetes.

C L Hitchcock, W J Riley, A Alamo, R Pyka, N K Maclaren.   

Abstract

Peripheral blood lymphocytes were obtained from 65 individuals: 34 nondiabetic patients with islet cell autoantibodies (ICA) (prediabetic phase), 9 patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM), 6 ICA-negative siblings or offsprings of IDDM patients, and 16 ICA-negative controls. The presence of lymphocyte abnormalities and/or activation was examined with dual fluorescence flow cytometry. The percentages of B cells, total T-lymphocyte, and helper T-lymphocyte (Th) and cytotoxic/suppressor T-lymphocyte (Tc/s) subsets and their ratio were not significantly different among the patient groups. No increased expression of interleukin 2 receptor on T-lymphocyte was found in newly diagnosed IDDM or prediabetic individuals. Sixteen of 49 patients had significantly increased number of T-lymphocyte expressing HLA-DR. A significant increase in the number of both Th and Tc/s subsets expressing HLA-DR was found in only 3 of 16 patients. This increase was unrelated to the patients's relative ICA titer or HLA-DR phenotype. On the other hand, the relative density of the DR antigen (RAD-DR) was significantly increased on both Th (886 +/- 120) and Tc/s (1250 +/- 273) in 13 of 38 patients compared with control patients (Th 484 +/- 129 and Tc/s 460 +/- 166). The RAD-DR on Tc/s correlated with the relative ICA titer and was greatest on DR3/4-phenotyped T-lymphocytes. In addition, significantly increased RAD-DR was found in noncontrol patients with impaired insulin release responses at 1 and 3 min to intravenous glucose.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533686     DOI: 10.2337/diab.35.12.1416

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  The Vogt-Koyanagi-Harada syndrome: association with hypothyroidism and diabetes mellitus.

Authors:  N Jaggarao; D Voth; J Jacobsen
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

2.  Abnormalities within CD4 and CD8 T lymphocytes subsets in type 1 (insulin-dependent) diabetes.

Authors:  J Ilonen; H M Surcel; M L Käär
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

3.  Persistent reduction of CD4/CD8 lymphocyte ratio and cell activation before the onset of type 1 (insulin-dependent) diabetes.

Authors:  L Al-Sakkaf; P Pozzilli; A C Tarn; G Schwarz; E A Gale; G F Bottazzo
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

4.  High serum levels of soluble CD8 in insulin-dependent diabetes.

Authors:  E Di Cesare; M Previti; M C Ingemi; G F Bagnato; D Cucinotta
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

5.  Cytokines in sera from insulin-dependent diabetic patients at diagnosis.

Authors:  M G Cavallo; P Pozzilli; C Bird; M Wadhwa; A Meager; N Visalli; A J Gearing; D Andreani; R Thorpe
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

6.  Evidence from twins for acquired cellular immune hyperactivity in type 1 diabetes.

Authors:  Nikolai Petrovsky; Kirsten O Kyvik; Vagn Bonnevie-Nielsen; Henning Beck-Nielsen; Anders Green; Leonard C Harrison
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

7.  Alterations of lymphocyte subsets in children of diabetic mothers.

Authors:  U Roll; J Scheeser; E Standl; A G Ziegler
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.